Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
Cardiovasc Diabetol. 2021 Jan 19;20(1):20. doi: 10.1186/s12933-021-01215-8.
The metabolic syndrome (MetS) and its components are associated with the development of atrial fibrillation (AF). However, the impact of time-burden of MetS on the risk of AF is unknown. We investigated the effect of the cumulative longitudinal burden of MetS on the development of AF.
We included 2 885 189 individuals without AF who underwent four annual health examinations during 2009-2013 from the database of the Korean national health insurance service. Metabolic burdens were evaluated in the following three ways: (1) cumulative number of MetS diagnosed at each health examination (0-4 times); (2) cumulative number of each MetS component diagnosed at each health examination (0-4 times per MetS component); and (3) cumulative number of total MetS components diagnosed at each health examination (0 to a maximum of 20). The risk of AF according to the metabolic burden was estimated using Cox proportional-hazards models.
Of all individuals, 62.4%, 14.8%, 8.7%, 6.5%, and 7.6% met the MetS diagnostic criteria 0, 1, 2, 3, and 4 times, respectively. During a mean follow-up of 5.3 years, the risk of AF showed a positive association with the cumulative number of MetS diagnosed over four health examinations: adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) of 1, 2, 3, and 4 times compared to 0 times were 1.18 (1.13-1.24), 1.31 (1.25-1.39), 1.46 (1.38-1.55), and 1.72 (1.63-1.82), respectively; P for trend < 0.001. All five components of MetS, when diagnosed repeatedly, were independently associated with an increased risk of AF: adjusted HR (95% CI) from 1.22 (1.15-1.29) for impaired fasting glucose to 1.96 (1.87-2.07) for elevated blood pressure. As metabolic components were accumulated from 0 to 20 counts, the risk of AF also gradually increased up to 3.1-fold (adjusted HR 3.11, 95% CI 2.52-3.83 in those with 20 cumulative components of MetS), however, recovery from MetS was linked to a decreased risk of AF.
Given the positive correlations between the cumulative metabolic burdens and the risk of incident AF, maximal effort to detect and correct metabolic derangements even before MetS development might be important to prevent AF and related cardiovascular diseases.
代谢综合征(MetS)及其各组分与心房颤动(AF)的发生发展相关。然而,MetS 时间负担对 AF 风险的影响尚不清楚。本研究旨在探讨 MetS 累积纵向负担对 AF 发生的影响。
我们纳入了 2885189 名在 2009-2013 年期间接受了 4 次年度健康检查且无 AF 的个体,这些个体来自韩国国民健康保险服务数据库。采用以下三种方法评估代谢负担:(1)每次健康检查时诊断出的 MetS 次数(0-4 次);(2)每次健康检查时诊断出的各 MetS 组分次数(0-4 次/MetS 组分);(3)每次健康检查时诊断出的总 MetS 组分次数(0 至最高 20 次)。采用 Cox 比例风险模型估计 AF 发生风险与代谢负担之间的关系。
在所有个体中,分别有 62.4%、14.8%、8.7%、6.5%和 7.6%的个体符合 MetS 诊断标准 0、1、2、3 和 4 次。在平均 5.3 年的随访期间,AF 发生风险与四次健康检查中诊断出的 MetS 次数呈正相关:与诊断 0 次相比,诊断 1、2、3 和 4 次的校正风险比(HRs)及其 95%置信区间(CIs)分别为 1.18(1.13-1.24)、1.31(1.25-1.39)、1.46(1.38-1.55)和 1.72(1.63-1.82);P 值均<0.001。当各 MetS 组分重复诊断时,它们与 AF 风险增加独立相关:从空腹血糖受损的校正 HR(95%CI)1.22(1.15-1.29)到血压升高的校正 HR 1.96(1.87-2.07)。随着代谢组分从 0 个累积到 20 个,AF 风险也逐渐增加,最高可达 3.1 倍(累积 20 个 MetS 组分的校正 HR 3.11,95%CI 2.52-3.83),但 MetS 的缓解与 AF 风险降低有关。
鉴于累积代谢负担与 AF 发生风险之间存在正相关关系,因此,即使在 MetS 发生之前,也应最大程度地努力检测和纠正代谢异常,这可能对预防 AF 及相关心血管疾病至关重要。